By
Tim Beyers
|
More Articles
February 3, 2006
|
On Feb. 2, Intuitive Surgical (Nasdaq: ISRG ) released Q4 and fiscal 2005 earnings for the period ended Dec. 31, 2005.
- Fourth-quarter sales of $72.1 million easily outpaced Street estimates. Earnings, too, were higher than analysts expected, but a $24 million tax benefit helped the company achieve EPS of $1.31.
- The company sold 40 of its da Vinci Surgical Systems during Q4, which makes 116 for the full year. That's a 53% increase from the 76 sold during 2004.
(Figures in thousands, except per-share data)
Income Statement Highlights
|
Avg. Est.
|
Q4 2005
|
Q4 2004
|
% Change
|
|
Sales
|
$65,070
|
$72,095
|
$45,194
|
+59.5%
|
|
Net Profit
|
--
|
$49,525
|
$11,682
|
+323.9%
|
|
EPS
|
$0.49
|
$1.31
|
$0.32
|
+309.4%
|
Get back to basics with a look at the income statement.
Margin Checkup
|
Q4 2005
|
Q4 2004
|
Change
|
|
Gross Margin
|
67.36%
|
65.95%
|
+1.41%
|
|
Op. Margin
|
32.61%
|
24.22%
|
+8.39%
|
|
Net Margin
|
68.69%
|
25.85%
|
+42.85%
|
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets
|
Q4 2005
|
Q4 2004
|
% Change
|
|
Cash+ ST Invest.
|
$202,739
|
$132,038
|
+53.5%
|
|
Inventory
|
$15,170
|
$5,966
|
+154.3%
|
|
Accounts Rec.
|
$52,849
|
$35,443
|
+49.1%
|
|
Liabilities
|
|
|
|
|
Long-Term Debt
|
$-
|
$-
|
N/A
|
|
Accounts Pay.
|
$7,950
|
$4,485
|
+77.3%
|
Cash Flow Highlights
No cash flow statement provided. (Whatever.)
Find out why Fools always follow the money.
Related Companies:
- Biomet (Nasdaq: BMET )
- BostonScientific (NYSE: BSX )
- Johnson & Johnson (NYSE: JNJ )
- Medtronic (NYSE: MDT )
- Smith & Nephew (NYSE: SNN )
- St.Jude Medical (NYSE: STJ )
Related Foolishness:
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so checkFool.comfor more of our in-depth discussion of what the numbers mean.
Intuitive Surgical is aMotley Fool Rule Breakers selection. David Gardner looks for stocks that are a step ahead of the rest. For more on his newsletter,click here.
Fool contributorTim Beyersdidn't own shares in any of the companies mentioned in this story at the time of publication. You can find out what is in his portfolio by checking Tim's Foolprofile. The Motley Fool has an ironcladdisclosure policy.
RSS Headlines
Fool UK